tDCS to Decrease Opioid Relapse (UH3)
tDCS to Decrease Opioid Relapse (UH3)
Recruiting · NCT06432465 · Registry updated 2026-06-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| tDCS to Decrease Opioid Relapse (UH3) | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-06-29 | NCT06432465 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Butler Hospital | 21 |
| National Institute on Drug Abuse (NIDA) | 549 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Butler Hospital | Providence | United States | 22 |